GAMCO INVESTORS, INC. ET AL - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$2,649,000
+15.7%
61,300
+13.1%
0.02%
+41.7%
Q2 2015$2,290,000
+3.2%
54,200
-5.2%
0.01%0.0%
Q1 2015$2,218,000
+15.2%
57,2000.0%0.01%
+20.0%
Q4 2014$1,926,000
-3.8%
57,2000.0%0.01%
-9.1%
Q3 2014$2,003,000
+6.5%
57,2000.0%0.01%
+10.0%
Q2 2014$1,880,000
-14.6%
57,200
-4.2%
0.01%
-16.7%
Q1 2014$2,201,000
-12.0%
59,700
-8.4%
0.01%
-7.7%
Q4 2013$2,502,000
+5.4%
65,200
-24.7%
0.01%
-7.1%
Q3 2013$2,373,000
-3.5%
86,600
-26.0%
0.01%
-6.7%
Q2 2013$2,459,000117,1000.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders